Phenominer Database Results (11 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Clinical Measurement Notes Record ID Study ID
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 100.0 % 0.0 in vivo caliper method 0.0 0 Experiment 1 109481 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 89.8 % 14.0 in vivo caliper method 0.0 0 Experiment 2 109489 3146
LOU/M time from start of drug therapy to immunocytoma regrowth rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 21.6 d 1.3 in vivo caliper method 0.0 0 Experiment 2 109494 3146
LOU/M post-treatment survival time from drug-treated IgM immunocytoma rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (4 mg/kg) (for 42 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. life span trait both 154 days-193 days 7 31.0 d 1.51 4.0 necropsy 0.0 0 post-treatment survival time from drug-treated IgM immunocytoma (CMO:0003867) 109476 3146
LOU/M post-treatment survival time from drug-treated IgM immunocytoma rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (2 mg/kg) (for 49 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. life span trait both 154 days-193 days 7 35.0 d 2.65 7.0 necropsy 0.0 0 post-treatment survival time from drug-treated IgM immunocytoma (CMO:0003867) 109477 3146
LOU/M time from therapy-induced maximal immunocytoma size decrease to regrowth of tumor to a diameter of 10 mm rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 7 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 8.6 d 3.4 in vivo caliper method 0.0 0 Experiment 2 109498 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.5 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 66.7 % 25.4 in vivo caliper method 0.0 0 Experiment 2 109488 3146
LOU/M time from start of drug therapy to immunocytoma regrowth rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.5 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 19.2 d 3.2 in vivo caliper method 0.0 0 Experiment 2 109493 3146
LOU/M time from therapy-induced maximal immunocytoma size decrease to regrowth of tumor to a diameter of 10 mm rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.5 mg/kg) (for 7 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 4.6 d 2.6 in vivo caliper method 0.0 0 Experiment 2 109497 3146
LOU/M time from start of drug therapy to immunocytoma regrowth rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 35 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 35.0 d 7.7 in vivo caliper method 0.0 0 Experiment 1 109484 3146
LOU/M maximum tumor size decrease to pretreatment tumor size ratio rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.25 mg/kg) (for 21 days) de Jong WH, etal., Cancer Res. 1983 Oct;43(10):4927-34. hypodermis integrity trait both 154 days-193 days 0 29.3 % 23.3 in vivo caliper method 0.0 0 Experiment 2 109487 3146